BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38046002)

  • 21. The Risk of Cardiovascular Events in Individuals With Primary Glomerular Diseases.
    Canney M; Gunning HM; Zheng Y; Rose C; Jauhal A; Hur SA; Sahota A; Reich HN; Barbour SJ
    Am J Kidney Dis; 2022 Dec; 80(6):740-750. PubMed ID: 35659570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial.
    Garimella PS; Lee AK; Ambrosius WT; Bhatt U; Cheung AK; Chonchol M; Craven T; Hawfield AT; Jotwani V; Killeen A; Punzi H; Sarnak MJ; Wall BM; Ix JH; Shlipak MG
    Eur Heart J; 2019 Nov; 40(42):3486-3493. PubMed ID: 31257404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinal changes and cardiac biomarker assessment in relation to chronic kidney disease: a single centre study.
    Mustafar R; Hishamuddin KAM; Mohd R; Kamaruzaman L; Halim WHWA; Hsien YM; Sze TK; Zaki WMDW; Ali A; Bain A
    BMC Nephrol; 2023 Nov; 24(1):338. PubMed ID: 37957551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progression of Chronic Kidney Disease Risk Categories and Risk of Cardiovascular Disease and Total Mortality: Coronary Artery Risk Development in Young Adults Cohort.
    Choi Y; Jacobs DR; Shroff GR; Kramer H; Chang AR; Duprez DA
    J Am Heart Assoc; 2022 Nov; 11(21):e026685. PubMed ID: 36314497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of estimated glomerular filtration rate to predict incident chronic kidney disease in patients at risk of cardiovascular disease: a retrospective study.
    Al-Shamsi S; Oulhaj A; Regmi D; Govender RD
    BMC Nephrol; 2019 Aug; 20(1):325. PubMed ID: 31429712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporating kidney disease measures into cardiovascular risk prediction: Development and validation in 9 million adults from 72 datasets.
    Matsushita K; Jassal SK; Sang Y; Ballew SH; Grams ME; Surapaneni A; Arnlov J; Bansal N; Bozic M; Brenner H; Brunskill NJ; Chang AR; Chinnadurai R; Cirillo M; Correa A; Ebert N; Eckardt KU; Gansevoort RT; Gutierrez O; Hadaegh F; He J; Hwang SJ; Jafar TH; Kayama T; Kovesdy CP; Landman GW; Levey AS; Lloyd-Jones DM; Major RW; Miura K; Muntner P; Nadkarni GN; Naimark DM; Nowak C; Ohkubo T; Pena MJ; Polkinghorne KR; Sabanayagam C; Sairenchi T; Schneider MP; Shalev V; Shlipak M; Solbu MD; Stempniewicz N; Tollitt J; Valdivielso JM; van der Leeuw J; Wang AY; Wen CP; Woodward M; Yamagishi K; Yatsuya H; Zhang L; Schaeffner E; Coresh J
    EClinicalMedicine; 2020 Oct; 27():100552. PubMed ID: 33150324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Chen Y; Zelnick LR; Huber MP; Wang K; Bansal N; Hoofnagle AN; Paranji RK; Heckbert SR; Weiss NS; Go AS; Hsu CY; Feldman HI; Waikar SS; Mehta RC; Srivastava A; Seliger SL; Lash JP; Porter AC; Raj DS; Kestenbaum BR;
    Am J Kidney Dis; 2021 Aug; 78(2):226-235.e1. PubMed ID: 33421453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic syndrome and retinal microvascular calibre in a high cardiovascular disease risk cohort.
    Wang SB; Mitchell P; Plant AJ; Phan K; Liew G; Thiagalingam A; Burlutsky G; Gopinath B
    Br J Ophthalmol; 2016 Aug; 100(8):1041-6. PubMed ID: 26531050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP.
    Matsushita K; Kaptoge S; Hageman SHJ; Sang Y; Ballew SH; Grams ME; Surapaneni A; Sun L; Arnlov J; Bozic M; Brenner H; Brunskill NJ; Chang AR; Chinnadurai R; Cirillo M; Correa A; Ebert N; Eckardt KU; Gansevoort RT; Gutierrez O; Hadaegh F; He J; Hwang SJ; Jafar TH; Jassal SK; Kayama T; Kovesdy CP; Landman GW; Levey AS; Lloyd-Jones DM; Major RW; Miura K; Muntner P; Nadkarni GN; Nowak C; Ohkubo T; Pena MJ; Polkinghorne KR; Sairenchi T; Schaeffner E; Schneider MP; Shalev V; Shlipak MG; Solbu MD; Stempniewicz N; Tollitt J; Valdivielso JM; van der Leeuw J; Wang AY; Wen CP; Woodward M; Yamagishi K; Yatsuya H; Zhang L; Dorresteijn JAN; Di Angelantonio E; Visseren FLJ; Pennells L; Coresh J
    Eur J Prev Cardiol; 2023 Jan; 30(1):8-16. PubMed ID: 35972749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.
    McCullough PA; Li S; Jurkovitz CT; Stevens L; Collins AJ; Chen SC; Norris KC; McFarlane S; Johnson B; Shlipak MG; Obialo CI; Brown WW; Vassalotti J; Whaley-Connell AT; Brenner RM; Bakris GL;
    Am Heart J; 2008 Aug; 156(2):277-83. PubMed ID: 18657657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of predictability of future cardiovascular events between chronic kidney disease (CKD) stage based on CKD epidemiology collaboration equation and that based on modification of diet in renal disease equation in the Japanese general population--Iwate KENCO Study.
    Ohsawa M; Tanno K; Itai K; Turin TC; Okamura T; Ogawa A; Ogasawara K; Fujioka T; Onoda T; Yoshida Y; Omama S; Ishibashi Y; Nakamura M; Makita S; Tanaka F; Kuribayashi T; Koyama T; Sakata K; Okayama A
    Circ J; 2013; 77(5):1315-25. PubMed ID: 23428718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial function, arterial stiffness and Framingham risk score in chronic kidney disease: A prospective observational cohort study.
    Li Y; Guo X; Liang S; Li P; Chen P; Zheng Y; Wu J; Chen X; Cai G
    Hypertens Res; 2023 Apr; 46(4):868-878. PubMed ID: 36631552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinal vascular geometry and 6 year incidence and progression of diabetic retinopathy.
    Cheung CY; Sabanayagam C; Law AK; Kumari N; Ting DS; Tan G; Mitchell P; Cheng CY; Wong TY
    Diabetologia; 2017 Sep; 60(9):1770-1781. PubMed ID: 28623387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of retinal venular tortuosity with impaired renal function in the Northern Ireland Cohort for the Longitudinal Study of Ageing.
    O'Neill RA; Maxwell AP; Kee F; Young I; McGuinness B; Hogg RE; Gj M
    BMC Nephrol; 2020 Sep; 21(1):382. PubMed ID: 32883218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinopathy and Risk of Kidney Disease in Persons With Diabetes.
    Hong J; Surapaneni A; Daya N; Selvin E; Coresh J; Grams ME; Ballew SH
    Kidney Med; 2021; 3(5):808-815.e1. PubMed ID: 34693260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinal arteriolar tortuosity and fractal dimension are associated with long-term cardiovascular outcomes in people with type 2 diabetes.
    Sandoval-Garcia E; McLachlan S; Price AH; MacGillivray TJ; Strachan MWJ; Wilson JF; Price JF
    Diabetologia; 2021 Oct; 64(10):2215-2227. PubMed ID: 34160658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinal vascular profile in predicting incident cardiometabolic diseases among individuals with diabetes.
    Betzler BK; Sabanayagam C; Tham YC; Cheung CY; Cheng CY; Wong TY; Nusinovici S
    Microcirculation; 2022 Jul; 29(4-5):e12772. PubMed ID: 35652745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accounting for the Competing Risk of Death to Predict Kidney Failure in Adults With Stage 4 Chronic Kidney Disease.
    Al-Wahsh H; Tangri N; Quinn R; Liu P; Ferguson Ms T; Fiocco M; Lam Md MSc NN; Tonelli M; Ravani P
    JAMA Netw Open; 2021 May; 4(5):e219225. PubMed ID: 33944922
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.